Insight Molecular DiagnosticsIMDX
那斯達克 · USD
4.34
+0.04
(+0.93%)
收盤 08/22 03:59 (UTC+8)
08/22 03:59 (UTC+8)
Insight Molecular DiagnosticsIMDX
4.34
+0.04
(+0.93%)
財務數據
損益表
- 0.00
- 0.00
- 0.00
- 0.01
- 0.02
- 0.01
- 0.00
- 0.01
- 0.00
- 0.00
- -
- -40.91
- 10.58
- 1192.17
- 43.88
- -75.77
- -49.81
- 338.08
- -97.19
- 646.88
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q2 | 2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | |
營業收入淨額 | 239 | 32 | 1,139 | 260 | 518 | 2,138 | 1,486 | 115 | 104 | 176 |
營業成本 | 82 | 17 | 643 | 121 | 168 | 813 | 891 | 65 | 54 | 131 |
營業毛利 | 157 | 15 | 496 | 139 | 350 | 1,325 | 595 | 50 | 50 | 45 |
營業費用 | 11,559 | 4,428 | 23,931 | 11,187 | 10,192 | 8,124 | 34,222 | 13,565 | 4,682 | 5,831 |
研發費用 | 4,486 | 4,953 | 5,829 | 3,878 | 3,281 | 2,924 | 2,257 | 2,817 | 2,453 | 2,312 |
推銷及管理費用 | 7,073 | -525 | 3,502 | 7,309 | 6,911 | 5,200 | -9,935 | 10,748 | 2,229 | 3,460 |
非經常性項目費用 | - | - | 14,600 | - | - | - | 41,900 | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -11,402 | -4,413 | -23,435 | -11,048 | -9,842 | -6,799 | -33,627 | -13,515 | -4,632 | -5,786 |
其他收入及費用 | 162 | 146 | 506 | 223 | 125 | 157 | 146 | 53 | 110 | - |
利息費用 | 20 | 23 | 26 | 29 | 25 | 29 | 30 | 31 | 8 | 15 |
稅前純益 | -11,260 | -4,290 | -22,955 | -10,854 | -9,742 | -6,671 | -33,511 | -13,493 | -4,530 | -9,129 |
所得稅 | - | - | - | - | - | - | - | - | - | - |
稅後純益 | -11,260 | -4,290 | -22,955 | -10,854 | -9,742 | -6,671 | -33,511 | -13,493 | -4,530 | -9,129 |
基本每股稅後盈餘(元) | -0.31 | -0.12 | -0.72 | -0.34 | -0.30 | -0.26 | -1.93 | -0.98 | -0.36 | -1.13 |
稀釋每股稅後盈餘(元) | -0.32 | -0.12 | -0.74 | -0.34 | -0.31 | -0.26 | -2.30 | -1.04 | -0.19 | -1.13 |
基本平均股數(千股) | 36750.00 | 34519.00 | 32065.00 | 32033.00 | 32023.00 | 25694.00 | 17382.00 | 13714.00 | 12870.00 | 8264.00 |
稀釋平均股數(千股) | 36750.00 | 34519.00 | 32065.00 | 32033.00 | 32023.00 | 25694.00 | 17382.00 | 13714.00 | 12870.00 | 8264.00 |
還原基本每股稅後盈餘(元) | -0.31 | -0.12 | -0.72 | -0.34 | -0.30 | -0.26 | -1.93 | -0.98 | -0.36 | -1.13 |
還原稀釋每股稅後盈餘(元) | -0.32 | -0.12 | -0.74 | -0.34 | -0.31 | -0.26 | -2.30 | -1.04 | -0.19 | -1.13 |
還原基本平均股數(千股) | 36,750 | 34,519 | 32,065 | 32,033 | 32,023 | 25,694 | 17,382 | 13,714 | 12,870 | 8,264 |
還原稀釋平均股數(千股) | 36,750 | 34,519 | 32,065 | 32,033 | 32,023 | 25,694 | 17,382 | 13,714 | 12,870 | 8,264 |
EBITDA(千元) | -10,575 | -3,636 | -22,366 | -10,241 | -9,158 | -6,151 | -32,918 | -13,122 | -4,196 | -8,779 |